134 related articles for article (PubMed ID: 35874751)
1. Omicron Booster in Ancestral Strain Vaccinated Mice Augments Protective Immunities Against Both Delta and Omicron Variants.
Jia L; Zhou Y; Li S; Zhang Y; Yan D; Wang W; Zhang W; Wan Y; Qiu C
Front Immunol; 2022; 13():897879. PubMed ID: 35874751
[TBL] [Abstract][Full Text] [Related]
2. The Third dose of CoronVac vaccination induces broad and potent adaptive immune responses that recognize SARS-CoV-2 Delta and Omicron variants.
Chen Y; Chen L; Yin S; Tao Y; Zhu L; Tong X; Mao M; Li M; Wan Y; Ni J; Ji X; Dong X; Li J; Huang R; Shen Y; Shen H; Bao C; Wu C
Emerg Microbes Infect; 2022 Dec; 11(1):1524-1536. PubMed ID: 35608053
[TBL] [Abstract][Full Text] [Related]
3. Immunity against Delta and Omicron variants elicited by homologous inactivated vaccine booster in kidney transplant recipients.
Zhang L; Yang J; Lai C; Wan L; Xiong S; Kong W; Liu Z; Yu P; Chen M; Mai W; Khan SA; Deng M; Chen L; Lei Y; Zhou Q; Yu N; Li P; Chen Z; Ji T
Front Immunol; 2022; 13():1042784. PubMed ID: 36700230
[TBL] [Abstract][Full Text] [Related]
4. Mucosal immunization with Ad5-based vaccines protects Syrian hamsters from challenge with omicron and delta variants of SARS-CoV-2.
Braun MR; Martinez CI; Dora EG; Showalter LJ; Mercedes AR; Tucker SN
Front Immunol; 2023; 14():1086035. PubMed ID: 36911687
[TBL] [Abstract][Full Text] [Related]
5. A nasal omicron vaccine booster elicits potent neutralizing antibody response against emerging SARS-CoV-2 variants.
Lam JY; Ng YY; Yuen CK; Wong WM; Yuen KY; Kok KH
Emerg Microbes Infect; 2022 Dec; 11(1):964-967. PubMed ID: 35275039
[TBL] [Abstract][Full Text] [Related]
6. Generation of neutralizing antibodies against Omicron, Gamma and Delta SARS-CoV-2 variants following CoronaVac vaccination.
Silva ARD; Villas-Boas LS; Tozetto-Mendoza TR; Honorato L; Paula A; Witkin SS; Mendes-Correa MC
Rev Inst Med Trop Sao Paulo; 2022; 64():e19. PubMed ID: 35239863
[TBL] [Abstract][Full Text] [Related]
7. A fourth dose of Omicron RBD vaccine enhances broad neutralization against SARS-CoV-2 variants including BA.1 and BA.2 in vaccinated mice.
Zhou B; Song S; Guo H; Zhou X; Fan Q; Liu W; Cheng L; Ge X; Ju B; Zhang Z
J Med Virol; 2022 Aug; 94(8):3992-3997. PubMed ID: 35474319
[TBL] [Abstract][Full Text] [Related]
8. Intradermal administration of DNA vaccine targeting Omicron SARS-CoV-2 via pyro-drive jet injector provides the prolonged neutralizing antibody production via germinal center reaction.
Hayashi H; Sun J; Yanagida Y; Otera T; Tai JA; Nishikawa T; Yamashita K; Sakaguchi N; Yoshida S; Baba S; Chang CY; Shimamura M; Okamoto S; Amaishi Y; Chono H; Mineno J; Rakugi H; Morishita R; Nakagami H
Sci Rep; 2023 Aug; 13(1):13033. PubMed ID: 37563266
[TBL] [Abstract][Full Text] [Related]
9. Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies.
Aparicio B; Ruiz M; Casares N; Silva L; Egea J; Pérez P; Albericio G; Esteban M; García-Arriaza J; Lasarte JJ; Sarobe P
Front Immunol; 2022; 13():1044025. PubMed ID: 36761163
[TBL] [Abstract][Full Text] [Related]
10. Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With Ocrelizumab.
Madelon N; Heikkilä N; Sabater Royo I; Fontannaz P; Breville G; Lauper K; Goldstein R; Grifoni A; Sette A; Siegrist CA; Finckh A; Lalive PH; Didierlaurent AM; Eberhardt CS
JAMA Neurol; 2022 Apr; 79(4):399-404. PubMed ID: 35212717
[TBL] [Abstract][Full Text] [Related]
11. Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant.
Schubert M; Bertoglio F; Steinke S; Heine PA; Ynga-Durand MA; Maass H; Sammartino JC; Cassaniti I; Zuo F; Du L; Korn J; Milošević M; Wenzel EV; Krstanović F; Polten S; Pribanić-Matešić M; Brizić I; Baldanti F; Hammarström L; Dübel S; Šustić A; Marcotte H; Strengert M; Protić A; Piralla A; Pan-Hammarström Q; Čičin-Šain L; Hust M
BMC Med; 2022 Mar; 20(1):102. PubMed ID: 35236358
[TBL] [Abstract][Full Text] [Related]
12. T-cell responses to SARS-CoV-2 Omicron spike epitopes with mutations after the third booster dose of an inactivated vaccine.
Li Y; Wang X; Jin J; Ma Z; Liu Y; Zhang X; Su B
J Med Virol; 2022 Aug; 94(8):3998-4004. PubMed ID: 35474581
[TBL] [Abstract][Full Text] [Related]
13. Heterologous Omicron-adapted vaccine as a secondary booster promotes neutralizing antibodies against Omicron and its sub-lineages in mice.
Liu J; He Q; Gao F; Bian L; Wang Q; An C; Song L; Zhang J; Liu D; Song Z; Li L; Bai Y; Wang Z; Liang Z; Mao Q; Xu M
Emerg Microbes Infect; 2023 Dec; 12(1):e2143283. PubMed ID: 36377297
[TBL] [Abstract][Full Text] [Related]
14. A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants.
Lee IJ; Sun CP; Wu PY; Lan YH; Wang IH; Liu WC; Yuan JP; Chang YW; Tseng SC; Tsung SI; Chou YC; Kumari M; Lin YS; Chen HF; Chen TY; Lin CC; Chiu CW; Hsieh CH; Chuang CY; Cheng CM; Lin HT; Chen WY; Hsu FF; Hong MH; Liao CC; Chang CS; Liang JJ; Ma HH; Chiang MT; Liao HN; Ko HY; Chen LY; Ko YA; Yu PY; Yang TJ; Chiang PC; Hsu ST; Lin YL; Lee CC; Wu HC; Tao MH
J Biomed Sci; 2022 Jul; 29(1):49. PubMed ID: 35799178
[TBL] [Abstract][Full Text] [Related]
15. High Neutralizing Antibody Levels Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1 and BA.2 After UB-612 Vaccine Booster.
Guirakhoo F; Wang S; Wang CY; Kuo HK; Peng WJ; Liu H; Wang L; Johnson M; Hunt A; Hu MM; Monath TP; Rumyantsev A; Goldblatt D
J Infect Dis; 2022 Oct; 226(8):1401-1406. PubMed ID: 35723969
[TBL] [Abstract][Full Text] [Related]
16. Baculoviral COVID-19 Delta DNA vaccine cross-protects against SARS-CoV2 variants in K18-ACE2 transgenic mice.
Jang Y; Cho H; Chun J; Park K; Nowakowska A; Kim J; Lee H; Lee C; Han Y; Lee HJ; Shin HY; Kim YB
Vaccine; 2023 Feb; 41(6):1223-1231. PubMed ID: 36631359
[TBL] [Abstract][Full Text] [Related]
17. Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant.
Zang J; Yin Y; Xu S; Qiao W; Liu Q; Lavillette D; Zhang C; Wang H; Huang Z
Front Immunol; 2022; 13():908478. PubMed ID: 35844601
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of Booster Doses of the SARS-CoV-2 Inactivated Vaccine KCONVAC against the Mutant Strains.
Xiao C; Su J; Zhang C; Huang B; Mao L; Ren Z; Bai W; Li H; Lei G; Zheng J; Chen G; Liang X; Qiu C
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146822
[TBL] [Abstract][Full Text] [Related]
19. A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant.
He C; Yang J; Hong W; Chen Z; Peng D; Lei H; Alu A; He X; Bi Z; Jiang X; Jia G; Yang Y; Zhou Y; Yu W; Tang C; Huang Q; Yang M; Li B; Li J; Wang J; Que H; Chen L; Ren W; Wan D; Li J; Wang W; Shen G; Zhao Z; Yang L; Yang J; Wang Z; Su Z; Wei Y; Cen X; Tanaka Y; Song X; Lu S; Peng X; Lu G; Wei X
Nat Commun; 2022 Sep; 13(1):5459. PubMed ID: 36115859
[TBL] [Abstract][Full Text] [Related]
20. Impacts of delta and omicron variants on inactivated SARS-CoV-2 vaccine-induced T cell responses in patients with autoimmune diseases and healthy controls.
Wang S; Li J; Wang S; Ye Y; Li M; Liu Y; Chen B; Lai Y; Li L; Zhuang L; Peng S; Yang N; Zhang H; Xiao H
Clin Transl Med; 2023 Jan; 13(1):e1171. PubMed ID: 36639826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
